CN106975036A - A kind of compound deacidification tea and preparation method thereof - Google Patents
A kind of compound deacidification tea and preparation method thereof Download PDFInfo
- Publication number
- CN106975036A CN106975036A CN201710310188.3A CN201710310188A CN106975036A CN 106975036 A CN106975036 A CN 106975036A CN 201710310188 A CN201710310188 A CN 201710310188A CN 106975036 A CN106975036 A CN 106975036A
- Authority
- CN
- China
- Prior art keywords
- parts
- tea
- deacidification
- compound
- herbal medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a kind of compound deacidification tea and preparation method thereof, include the Main Ingredients and Appearance of following parts by weight：40 50 parts of Asiatic plantain, 10 30 parts of rhizoma imperatae, 20 40 parts of needles of pinus massoniana, 10 20 parts of smilax, 13 parts of the fruit of Chinese wolfberry.Compound deacidification tea, cures mainly high lithemia, high fat of blood, high cholesterol, gout, is to be formulated medicine by a variety of books on Chinese herbal medicine.Proved by practice test for many years; the compound deacidification tea can not only make high lithemia; uric acid is quick from kidney discharge in patient with gout body; and uric acid can be neutralized; renal function is protected, mitigates patient because gout brings pain, also with reducing blood lipid, norcholesterol; suppress the few plate aggregation of blood, reduce the effect of blood viscosity；It can reach the therapeutic purposes treated both principal and secondary aspect of disease and without any toxicity and side effects.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines, it particularly relates to a kind of compound deacidification tea and preparation method thereof.
Background technology
Hyperuricemia, is mainly caused, kidney is the main path of uric acid excretion, works as uric acid by renal function excretion is abnormal
Discharge will not exclusively increase uric acid in blood concentration.Uric acid is higher in blood, gout is very common disease, it may be said that be to cause
The root of many serious diseases.But the reason for uric acid is higher is all very universal, including diet, medicine etc..
1st, of excessive eating and drinking is principal element.When patient has been that uric acid is higher in blood, it is not careful in one's diet still, it is usually to eat more
Contain the food that many drift purine compositions are too high.Pluck, seafood, meat etc. are eaten than as usual, the crapulence such as have the beer, treat with courtesy is added sudden and violent
The custom of food, exacerbates the further rise of uric acid.
2nd, it is drug-induced.One due to drug poisoning or endogenous metabolites suppression uric acid excretion and re-absorption increase,
When anion transport system is suppressed, it may appear that such case, the important inhibiting factor of two of which is lactic acid and Mek-Tol Unit.
At present, there are nearly 90,000,000 patient with gout, potential patient 1.2 hundred million in China and the goat incidence of disease is also with annual 10%
Speed rise year by year；Goat turns into the second largest metabolic disease of the mankind after diabetes.Gout and the high relation ten of uric acid
Divide close, outside gout influence normal life, body and mind pain can be also brought to patient, late period can cause permanent joint distortion etc.
A series of lesion of physical functions.Treatment uric acid height, urarthritis patient often have with chemicals at present：Colchicin,
Oral Allopurinol and probenecid etc..But this kind of chemicals maintains the level of control uric acid limited, and there are many side effects, gives
Patient's treatment brings certain difficulty, and cures the symptoms, not the disease.
The content of the invention
In view of this, it is an object of the invention to provide a kind of compound deacidification tea, uric acid height, gouty joint are not only assisted in
Scorching patient is rapid from kidney excretion by uric acid, maintains body acid-base balance, reaches to consolidate and control target effect；Simultaneously, it may also be used for
Treat hyperlipidemia, high cholesterol, prostatitis, aphthae etc..The present invention is a kind of brand-new anti-trioxypurine, anti-gout, drop
The therapy of blood fat, norcholesterol.And it has no toxic side effect relative to general chemicals, use is more safe and effective.
A kind of compound deacidification tea, includes the Main Ingredients and Appearance of following parts by weight：40-50 parts of Asiatic plantain, 10-30 parts of rhizoma imperatae,
20-40 parts of needles of pinus massoniana, 10-20 parts of smilax, 1-3 parts of the fruit of Chinese wolfberry.
It is preferred that, described compound deacidification tea includes the Main Ingredients and Appearance of following parts by weight：45 parts of Asiatic plantain, rhizoma imperatae 25
Part, 30 parts of needles of pinus massoniana, 15 parts of smilax, 2 parts of the fruit of Chinese wolfberry.
It is preferred that, described compound deacidification tea includes the Main Ingredients and Appearance of following parts by weight：45 parts of Asiatic plantain, rhizoma imperatae 15
Part, 35 parts of needles of pinus massoniana, 12 parts of smilax, 2.5 parts of the fruit of Chinese wolfberry.
It is preferred that, described compound deacidification tea includes the Main Ingredients and Appearance of following parts by weight：48 parts of Asiatic plantain, rhizoma imperatae 18
Part, 25 parts of needles of pinus massoniana, 12 parts of smilax, 1.5 parts of the fruit of Chinese wolfberry.
The primary raw material of the present invention includes：
1st, Asiatic plantain：Uric acid in high lithemia, patient with gout body can be made to be discharged quickly through urine, the reduction of patient state of an illness.Tool
There are fine diuresis, antidiarrheal and eliminating the phlegm, improving eyesight effect；There is certain inhibitory action to tumour；With detumescence, heat-clearing, clear eliminating dampness
Effect.For treating urarthritis, chronic bronchitis, aphthae, prostatitis etc..
2nd, rhizoma imperatae：It is cold in nature it is sweet, with removing damp-heat diuresis, cooling blood and hemostasis, anti-inflammatory the effects such as.Cure mainly high fat of blood, tell
Blood, hematuria, heat gonorrhea, oedema, difficult urination etc..
3. masson pine：With the effect of bidirectional modulation blood pressure, there is softening blood vessel, increase blood vessel elasticity, make tissue young
Change, there is treatment apoplexy, arthralgia, clearing damp, tinea pedis and diabetes, can also reducing blood lipid, norcholesterol, and effectively adjust
Immunity.
4. smilax：The effects such as energy strengthening the spleen and stomach, wind-damp dispelling, sharp joint.《Interior warp》Smilax can dispel, and spleen is wet, and clearing damp is then sought and defended
So as to which muscles and bones arteries and veins is soft, muscle is real and contraction pain leakage is cured.Therefore there is removing toxic substances, dehumidifying, drop to urinate in the medicine when treating gout with smilax
The effect of acid, and have analgesic activity to joint, so smilax treatment gout can reach the therapeutic effect of colchicin, and
Without bounce-back, have no toxic side effect.
5th, the fruit of Chinese wolfberry：With reduction blood glucose, lipotropy, it is possible to antiatherosclerosis, the fruit of Chinese wolfberry is also to help
Just consolidate, production of sperm mends marrow, enriching yin and nourishing kidney, benefiting qi for tranquillization, physical fitness, the good medicine of anti-aging.
A kind of preparation method of compound deacidification tea, comprises the following steps：Chinese herbal medicine is chosen, through over cleaning, in clean environment
The middle sun, which is exposed to the sun to solid content, is more than 90%, then dries to solid content more than 99%, and under conditions of sterile, dustless, in
Medicine disintegrator grinds Chinese herbal medicine, and sieve powder is carried out with 120 mesh sieves, and through ultraviolet sterilization, equal mixture system, uses Chinese herbal medicine bag bag in proportion
Fill as health care tea bag.
It is preferred that, described Chinese herbal medicine is root, stem, the leaf of pollution-free pure natural wild Chinese herbal medicine.
The principle of compound deacidification tea of the present invention is：Treatment to anti-trioxypurine, gout is not that The faster the better for deacidification, but is needed
Want the therapeutic process of a long-term adjustment.Compound deacidification tea can not only be reduced effectively after urarthritis caused by high lithemia etc.
Disease is lost, while there is comprehensive adjustment effect to each internal organs of human body.The present invention is except can effectively alleviate gout, hyperuricemia patients pain
Bitterly, prevent beyond complication also thering is preferable drug effect to middle-aged and old Cardial or cerebral vascular diseases；There is reducing blood lipid simultaneously, suppress blood
Few plate aggregation, antithrombotic, norcholesterol, the blood dirt eliminated in blood, softening blood vessel improve Cardial or cerebral vascular diseases incidence.
Compound deacidification tea provided by the present invention, cures mainly high lithemia, high fat of blood, high cholesterol, gout, is by a variety of books on Chinese herbal medicine
It is formulated medicine.Proved by practice test for many years, the compound deacidification tea can not only make uric acid in high lithemia, patient with gout body
It is quick to be discharged from kidney, and uric acid can be neutralized, renal function is protected, mitigates patient because gout brings pain, also with reducing blood lipid, drop
Cholesterol, suppresses the few plate aggregation of blood, reduces the effect of blood viscosity；It can reach the therapeutic purposes treated both principal and secondary aspect of disease and nontoxic without pair
Effect.
Embodiment
Following examples, to further labor of the invention：
Embodiment 1
A kind of preparation method of compound deacidification tea, comprises the following steps：Chinese herbal medicine is chosen, through over cleaning, in clean environment
The middle sun, which is exposed to the sun to solid content, is more than 90%, then dries to solid content more than 99%, and under conditions of sterile, dustless, in
Medicine disintegrator grinds Chinese herbal medicine, and sieve powder is carried out with 120 mesh sieves, and through ultraviolet sterilization, equal mixture system, uses Chinese herbal medicine bag bag in proportion
Fill as health care tea bag.
Described compound deacidification tea, includes the Main Ingredients and Appearance of following parts by weight：45 parts of Asiatic plantain, 25 parts of rhizoma imperatae, horse hair
30 parts of pine needle, 15 parts of smilax, 2 parts of the fruit of Chinese wolfberry.
Embodiment 2
A kind of preparation method of compound deacidification tea, comprises the following steps：Chinese herbal medicine is chosen, through over cleaning, in clean environment
The middle sun, which is exposed to the sun to solid content, is more than 90%, then dries to solid content more than 99%, and under conditions of sterile, dustless, in
Medicine disintegrator grinds Chinese herbal medicine, and sieve powder is carried out with 120 mesh sieves, and through ultraviolet sterilization, equal mixture system, uses Chinese herbal medicine bag bag in proportion
Fill as health care tea bag.
Described compound deacidification tea, includes the Main Ingredients and Appearance of following parts by weight：45 parts of Asiatic plantain, 15 parts of rhizoma imperatae, horse hair
35 parts of pine needle, 12 parts of smilax, 2.5 parts of the fruit of Chinese wolfberry.
Embodiment 3
A kind of preparation method of compound deacidification tea, comprises the following steps：Chinese herbal medicine is chosen, through over cleaning, in clean environment
The middle sun, which is exposed to the sun to solid content, is more than 90%, then dries to solid content more than 99%, and under conditions of sterile, dustless, in
Medicine disintegrator grinds Chinese herbal medicine, and sieve powder is carried out with 120 mesh sieves, and through ultraviolet sterilization, equal mixture system, uses Chinese herbal medicine bag bag in proportion
Fill as health care tea bag.
Described compound deacidification tea, includes the Main Ingredients and Appearance of following parts by weight：48 parts of Asiatic plantain, 18 parts of rhizoma imperatae, horse hair
25 parts of pine needle, 12 parts of smilax, 1.5 parts of the fruit of Chinese wolfberry.
Choosing 100 hyperuricemia patients below, (wherein high fat of blood, the patient of high cholesterol complication are 70, and remaining 30
Example is patient with gout) to compound deacidification tea 60 days clinical trials of progress of embodiment 1, method of testing is suffered to choose 50 high lithemias
Person drinks compound deacidification tea 3 times and detects uric acid level after discontinuing medication 15 days in the morning, afternoon and evening for each person every day, and control group is using medicine
Allopurinol simultaneously detects uric acid level after discontinuing medication 15 days, obtains following test result, concrete outcome is shown in Table 1.
Table 1 is the result of clinical trial：
Cure：Symptom is wholly absent, and uric acid is reduced to normal level.
It is effective：Symptom is significantly taken a turn for the better earlier above, and uric acid is substantially reduced.
Effectively：Symptom take a favorable turn earlier above, and uric acid has reduction, but unobvious.
It is invalid：Symptom is without significant change, or has the trend of exacerbation.
Cure rate：Cure the ratio that test number is accounted for effective number.
By above clinic test data it is recognised that the therapeutic effect of Allopurinol is mainly control uric acid level rise, it is discontinued
Uric acid level can go up again afterwards, cure the symptoms, not the disease；And the compound deacidification tea of the present invention is treated both principal and secondary aspect of disease, effect is notable.
The foregoing is only a preferred embodiment of the present invention, but protection scope of the present invention be not limited thereto,
Any one skilled in the art the invention discloses technical scope in, technique according to the invention scheme and its
Inventive concept is subject to equivalent substitution or change, should all be included within the scope of the present invention.
Claims (6)
1. a kind of compound deacidification tea, it is characterised in that include the Main Ingredients and Appearance of following parts by weight：40-50 parts of Asiatic plantain, rhizoma imperatae
10-30 parts, 20-40 parts of needles of pinus massoniana, 10-20 parts of smilax, 1-3 parts of the fruit of Chinese wolfberry.
2. compound deacidification tea as claimed in claim 1, it is characterised in that include the Main Ingredients and Appearance of following parts by weight：Asiatic plantain
45 parts, 25 parts of rhizoma imperatae, 30 parts of needles of pinus massoniana, 15 parts of smilax, 2 parts of the fruit of Chinese wolfberry.
3. compound deacidification tea as claimed in claim 1, it is characterised in that include the Main Ingredients and Appearance of following parts by weight：Asiatic plantain
45 parts, 15 parts of rhizoma imperatae, 35 parts of needles of pinus massoniana, 12 parts of smilax, 2.5 parts of the fruit of Chinese wolfberry.
4. compound deacidification tea as claimed in claim 1, it is characterised in that include the Main Ingredients and Appearance of following parts by weight：Asiatic plantain
48 parts, 18 parts of rhizoma imperatae, 25 parts of needles of pinus massoniana, 12 parts of smilax, 1.5 parts of the fruit of Chinese wolfberry.
5. a kind of preparation method of compound deacidification tea, it is characterised in that comprise the following steps：Chinese herbal medicine is chosen, through over cleaning,
The sun, which is exposed to the sun to solid content, in clean environment is more than 90%, then dries to solid content more than 99%, and in sterile, dustless condition
Under, Chinese herbal medicine is ground with medicinal herb grinder, sieve powder is carried out with 120 mesh sieves, through ultraviolet sterilization, equal mixture system, is used in proportion
Chinese herbal medicine bag is packaged as health care tea bag.
6. the preparation method of compound deacidification tea as claimed in claim 5, it is characterised in that described Chinese herbal medicine is pollution-free pure
Root, stem, the leaf of wild Chinese herbal medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710310188.3A CN106975036A (en) | 2017-05-05 | 2017-05-05 | A kind of compound deacidification tea and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710310188.3A CN106975036A (en) | 2017-05-05 | 2017-05-05 | A kind of compound deacidification tea and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106975036A true CN106975036A (en) | 2017-07-25 |
Family
ID=59341404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710310188.3A Pending CN106975036A (en) | 2017-05-05 | 2017-05-05 | A kind of compound deacidification tea and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106975036A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107281323A (en) * | 2017-08-11 | 2017-10-24 | 中国科学院西北高原生物研究所 | Purposes of the black fruit fructus lycii powder in anti-trioxypurine or treatment gout product is prepared |
| CN107715082A (en) * | 2017-09-26 | 2018-02-23 | 吴建萍 | A kind of logical compound health preserving tea of profit |
-
2017
- 2017-05-05 CN CN201710310188.3A patent/CN106975036A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 欧广升: "《慢性病食疗妙方》", 30 September 2009, 湖南科学技术出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107281323A (en) * | 2017-08-11 | 2017-10-24 | 中国科学院西北高原生物研究所 | Purposes of the black fruit fructus lycii powder in anti-trioxypurine or treatment gout product is prepared |
| CN107281323B (en) * | 2017-08-11 | 2021-01-15 | 中国科学院西北高原生物研究所 | Application of lycium ruthenicum powder in preparation of uric acid reducing or gout treating products |
| CN107715082A (en) * | 2017-09-26 | 2018-02-23 | 吴建萍 | A kind of logical compound health preserving tea of profit |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107693767A (en) | A kind of external medicine composition, its preparation method and application for preventing and treating diabetes | |
| CN106236875A (en) | A kind of Chinese medicine composition of liver heat removing and eyesight improving and preparation method thereof | |
| CN106975036A (en) | A kind of compound deacidification tea and preparation method thereof | |
| CN105031408B (en) | A kind of composition improving gout | |
| CN107773657A (en) | A kind of medicine for treating diabetes | |
| CN104547747A (en) | Fast-acting medicinal liquor for treating wind-cold-dampness arthralgia and application thereof | |
| CN106834032A (en) | The application of gout health care product or medicament is controlled in a kind of alcoholic drink mixed with fruit juice, preparation method and its preparation | |
| CN105770798A (en) | Traditional Chinese medicine used for treating wind phlegm and blood stasis and meridian obstruction type cerebral infarction | |
| CN104606566A (en) | Traditional Chinese medicine composition for treating liver-yang hyperactivity hypertension and preparation method for traditional Chinese medicine composition | |
| CN105106820A (en) | Traditional Chinese medicine oral liquid applied to senile constipation and preparation method thereof | |
| CN105311210A (en) | Pharmaceutical composition for treating rheumatoid bone diseases | |
| CN104771604B (en) | A kind of drug for treating apoplexy, preparation method and preparation | |
| CN101785824B (en) | Chinese mediated liquor for tumor treatment | |
| CN106692873A (en) | Formula and preparation method of traditional Chinese medicine for treatimg hyperlipemia | |
| CN104042924A (en) | Chinese herba preparation capable of treating qi and blood deficiency osteoarthritis and preparation method thereof | |
| CN104689176B (en) | A kind of Chinese medicine preparation for treating knee osteoarthritis and preparation method thereof | |
| CN104922266A (en) | Antibacterial fluid for treating onychomycosis and tinea of feet and hands, and preparation method thereof | |
| CN104288285B (en) | Traditional Chinese medicine composition for treating ankylosing spondylitis by matching with ultramicro knife | |
| CN103990016B (en) | The Chinese medicine composition and its preparation and preparation method for the treatment of rheumatism bone disease | |
| CN117211107A (en) | Traditional Chinese medicine rice paper with physiotherapy effect and preparation method thereof | |
| CN113577152A (en) | Pharmaceutical composition and application thereof in preparation of nutritional muscle product | |
| CN103599370A (en) | Traditional Chinese medicine preparation for treating blood stasis type acute cholecystitis | |
| CN114159509A (en) | Hypoglycemic agent and preparation method thereof | |
| CN102366503A (en) | Traditional Chinese medicinal composition for treating gout | |
| CN107812153A (en) | Treat the Chinese medicine composition of rheumatic disease, include its emulsifiable paste and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170725 |
|
| WD01 | Invention patent application deemed withdrawn after publication |